Filing Details

Accession Number:
0001144204-19-019738
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-15 19:07:04
Reporting Period:
2016-12-06
Accepted Time:
2019-04-15 19:07:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1586554 Target Group Inc. CBDY Medicinal Chemicals & Botanical Products (2833) 463610035
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635896 Rubin Schindermann 55 Administration Rd. Unit #13
Toronto A6 L4K 4G9
Ceo/Director Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-15 13,000 $0.12 9,075,706 No 4 S Direct
Common Stock Disposition 2019-02-21 50,000 $0.11 9,088,706 No 4 S Direct
Common Stock Disposition 2019-02-15 50,000 $0.10 9,138,706 No 4 S Direct
Common Stock Disposition 2019-01-25 6,165 $0.10 9,188,706 No 4 S Direct
Common Stock Disposition 2019-01-22 20,000 $0.10 9,194,871 No 4 S Direct
Common Stock Disposition 2019-01-14 23,835 $0.10 9,214,871 No 4 S Direct
Common Stock Acquisiton 2018-03-07 1,764,706 $0.02 9,238,706 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Preferred Stock Acquisiton 2016-12-06 500,000 $0.00 500,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
500,000 2017-02-04 No 4 A Direct
Footnotes
  1. The shares were issued pursuant to the Reporting Person's employment agreement in lieu of cash compensation.
  2. One (1) share of common stock is issuable for each one (1) share of preferred upon conversion.
  3. There is no expiration date for the exercise of the conversion rights of the preferred stock.
  4. The preferred shares were issued in consideration of $13,250 of deferred and unpaid compensation owed by the Issuer to the Reporting Person.